BCM
Bayesian Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
+4,373
| New | +$202K | 0.03% | 459 |
|
|
2024
Q4 | – | Sell |
-18,200
| Closed | -$942K | – | 704 |
|
|
2024
Q3 | $942K | Buy |
18,200
+6,300
| +53% | +$326K | 0.11% | 250 |
|
|
2024
Q2 | $494K | Buy |
+11,900
| New | +$494K | 0.06% | 373 |
|
|
2024
Q1 | – | Sell |
-104,800
| Closed | -$5.38M | – | 793 |
|
|
2023
Q4 | $5.38M | Buy |
+104,800
| New | +$5.38M | 0.57% | 28 |
|
|
2021
Q4 | – | Sell |
-17,597
| Closed | -$1.04M | – | 384 |
|
|
2021
Q3 | $1.04M | Buy |
17,597
+3,677
| +26% | +$218K | 0.3% | 85 |
|
|
2021
Q2 | $930K | Sell |
13,920
-44,270
| -76% | -$2.96M | 0.24% | 109 |
|
|
2021
Q1 | $3.67M | Buy |
58,190
+4,790
| +9% | +$302K | 0.85% | 18 |
|
|
2020
Q4 | $3.31M | Buy |
53,400
+35,000
| +190% | +$2.17M | 0.87% | 15 |
|
|
2020
Q3 | $1.11M | Sell |
18,400
-5,600
| -23% | -$338K | 0.27% | 94 |
|
|
2020
Q2 | $1.41M | Buy |
+24,000
| New | +$1.41M | 0.31% | 78 |
|
|
2019
Q2 | – | Sell |
-57,800
| Closed | -$2.76M | – | 520 |
|
|
2019
Q1 | $2.76M | Buy |
+57,800
| New | +$2.76M | 0.53% | 41 |
|
|
2018
Q2 | – | Sell |
-26,100
| Closed | -$1.65M | – | 600 |
|
|
2018
Q1 | $1.65M | Buy |
+26,100
| New | +$1.65M | 0.42% | 40 |
|
|
2017
Q3 | – | Sell |
-29,088
| Closed | -$1.62M | – | 483 |
|
|
2017
Q2 | $1.62M | Buy |
+29,088
| New | +$1.62M | 0.6% | 30 |
|
|
2017
Q1 | – | Sell |
-29,286
| Closed | -$1.71M | – | 421 |
|
|
2016
Q4 | $1.71M | Buy |
29,286
+25,486
| +671% | +$1.49M | 0.42% | 38 |
|
|
2016
Q3 | $205K | Buy |
+3,800
| New | +$205K | 0.13% | 284 |
|
|
2016
Q2 | – | Sell |
-4,194
| Closed | -$268K | – | 405 |
|
|
2016
Q1 | $268K | Buy |
+4,194
| New | +$268K | 0.25% | 188 |
|